FDA Basics Video Available about Drug Development for “Minor Use” in Major Species and For Specific Diseases Affecting “Minor Species”

As part of FDA Basics, FDA has posted a video with Dr. Margaret Oeller, director of FDA’s Office of Minor Use and Minor Species Animal Drug Development in the Center for Veterinary Medicine. Dr. Oeller discusses FDA’s role in encouraging drug development for specific “minor uses” in major species and for specific diseases affecting “minor species,” which include zoo animals, honeybees, game birds, and aquaculture. There are only seven major species; all other species are considered “minor species.” View the video below.